Treatment of aplastic anemia.
D000741:Anemia, Aplastic / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D001854:Bone Marrow Cells; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D006086:Graft vs Host Disease / Q000517:prevention & control; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007165:Immunosuppression Therapy; D007951:Leukemia, Myeloid / Q000209:etiology; D008221:Lymphoid Tissue / Q000528:radiation effects; D013601:T-Lymphocytes / Q000276:immunology; D065227:Transfusion Reaction; D014916:Whole-Body Irradiation
D000961:Antilymphocyte Serum; D001323:Autoantibodies; D003524:Cyclosporins